Clinical Trial Update: M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study of M-Gard Particulate EW for grass pollen–induced seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• M-Gard Particulate EW

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Allergic Rhinitis Due to Grass Pollens | Phase 2 | Status: COMPLETED